news
373

The FDA has authorized the Libre Duo, the first wearable device capable of continuously monitoring both blood sugar and ketone levels. This new dual-monitoring system is approved for use by individuals aged two and older living with diabetes.

Only full members can comment

Log in to express your opinion.

No comments yet.